Do you want to read an article? Please log in or register.
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis
Bronchi
RECOMMENDED
Related content
RECOMMENDED
COPD
Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Semin Respir Crit Care Med.
Gupta N, Haley R, Gupta A, Sethi S
doi: 10.1055/s-0040-1708837.
RECOMMENDED
COPDPneumonia
Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med.
Alispahic IA, Sørensen R, Eklöf J, Sivapalan P, Løkke A, Seersholm N, Vestergaard JH, Jensen JS
doi: 10.3390/jcm9051442.
RECOMMENDED
Further Publications
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Keir HR, Shoemark A, Dicker AJ, Perea L, Pollock J, Giam YH, Suarez-Cuartin G, Crichton ML, Lonergan M, Oriano M, Cant E, Einarsson GG, Furrie E, Elborn JS, Fong CJ, Finch S, Rogers GB, Blasi F, Sibila O, Aliberti S, Simpson JL, Huang JTJ, Chalmers JD
doi: 10.1016/S2213-2600(20)30504-X
RECOMMENDED
Bronchi
Vitamin D and disease severity in bronchiectasis
Respir Med.
Ferri S, Crimi C, Heffler E, Campisi R, Noto A, Crimi N
doi: 10.1016/j.rmed.
RECOMMENDED
Further Publications
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Choate R, Aksamit TR, Mannino D, Addrizzo-Harris D, Barker A, Basavaraj A, Daley CL, Daniels MLA, Eden E, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, McShane PJ, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Stone G
doi: 10.1016/j.rmed.2020.106285
RECOMMENDED
COPD
Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Semin Respir Crit Care Med.
Vasques F, Camporota L, Barrett NA
doi: 10.1055/s-0040-1714379.
AsthmaBronchi
Bronchiectasis in severe asthma: clinical features and outcomes
Ann Allergy Asthma Immunol.
Coman I, Pola-Bibián B, Barranco P, Vila-Nadal G, Dominguez-Ortega J, Romero D, Villasante C, Quirce S
doi: 10.1016/j.anai.2018.02.016.
COMMENTED
COPD
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Cochrane Database Syst Rev.
Vollenweider DJ, Frei A, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA
doi: 10.1002/14651858.
RECOMMENDED
Bronchi
Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
Lancet Respir Med.
Goyal V, Grimwood K, Ware RS, Byrnes CA, Morris PS, Masters IB, McCallum GB, Binks MJ, Smith-Vaughan H, O'Grady KF, Champion A, Buntain HM, Schultz A, Chatfield M, Torzillo PJ, Chang AB
doi: 10.1016/S2213-2600(19)30254-1.